Swedbank
COGT icon

Swedbank’s Cogent Biosciences COGT Stock Holding History

Swedbank’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$4.1M Buy
127,900
+9,500
+8% +$351K ﹤0.01% 588
2026
Q2 		$4.58M Buy
+118,400
New +$4.14M ﹤0.01% 591

Other funds holding COGT

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Tema ETFs
Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return
Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Swedbank's COGT Position: Q3 2026 in Review

Swedbank increased its Cogent Biosciences (COGT) stake by 8% in Q3 2026, buying an estimated $351K and bringing the position to 127,900 shares worth $4.1M. The position accounts for ﹤0.01% of the portfolio, ranked #588.

Swedbank first reported a position in COGT in Q2 2026 and has held it in 2 quarters since. The position peaked at $4.58M in Q2 2026. 43 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • Swedbank held 127,900 shares of Cogent Biosciences worth $4.1M as of Q3 2026.
  • Swedbank bought 9,500 Cogent Biosciences shares in Q3 2026, an estimated $351K.
  • Cogent Biosciences made up ﹤0.01% of Swedbank's portfolio in Q3 2026, its #588 holding.
  • Swedbank first reported a position in Cogent Biosciences in Q2 2026 and has held it in 2 quarters since.
  • Swedbank's Cogent Biosciences position peaked at $4.58M in Q2 2026.
  • 43 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on Swedbank's 13F filing for Q3 2026, filed 27 Oct 2026.